Technological offer

Novel glycolipid mimetics able to express anti-inflammatory or adjuvant activity in a context dependent manner. The compounds can be used for the treatment of immune diseases cursed with Th1/Th2 imbalance or as vaccine adjuvants.

Sensitive DVS that allows to perform foveation, computing temporal contrast on pixels for low and high resolution simultaneously. Ideal for applications requiring both high-speed motion detection and power efficiency, such as autonomous vehicles, robotics, and advanced surveillance systems.

Semiconducting and metallic films were obtained through the novel Massive Parallel Mechanical Exfoliation of van der Waals materials. They consist of ultrathin nanosheets with a thickness ranging from a few atomic layers to several layers of material.

Highly spherical, monodisperse particles made of titanium oxide can be synthesised in a sub and micrometre range under very mild conditions in a facile synthesis using commercial reactants. Applications in catalysis and photonics

New modal conversion architecture comprising two Y-junctions facing each other, with a subwavelength metamaterial structure in between them.

Catalytic material effective in the inactivation of airborne pathogens and with virucidal, fungicidal and bactericidal properties.

A new immunotherapy strategy based on the administration of a monoclonal antibody specific for pre-TCR has been developed and validated in a preclinical human T-ALL xenotransplantation model in mice.

Recombinant chimeric antigen used for the prevention or treatment of infections caused by Anaplasma phagocytophilum.

Inhibitor of Interferon type I (IFN-I) is capable of inhibiting the inflammatory response in those autoimmune diseases in which this cytokine is involved, called interferonopathies, such as systemic lupus erythematosus and Aicardi-Goutières syndrome.

A new immunotherapy strategy based on the administration of ADCs or CAR-T cells derived from a monoclonal antibody specific for the pre-TCR receptor, which impairs LIC activity and tumor progression, has been developed and validated in a preclinical human T-ALL xenotransplantation model in mice.